| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9109 |
| Human Intestinal Absorption | HIA+ | 0.9322 |
| Caco-2 Permeability | Caco2+ | 0.7583 |
| P-glycoprotein Substrate | Non-substrate | 0.8290 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9804 |
| Non-inhibitor | 0.9851 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9185 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7326 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7379 |
| CYP450 2D6 Substrate | Non-substrate | 0.8983 |
| CYP450 3A4 Substrate | Non-substrate | 0.8230 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8402 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7233 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9341 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9060 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9454 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8126 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9924 |
| Non-inhibitor | 0.9575 |
| AMES Toxicity | Non AMES toxic | 0.9300 |
| Carcinogens | Non-carcinogens | 0.7051 |
| Fish Toxicity | High FHMT | 0.8852 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.5188 |
| Honey Bee Toxicity | High HBT | 0.7076 |
| Biodegradation | Not ready biodegradable | 0.7124 |
| Acute Oral Toxicity | III | 0.6184 |
| Carcinogenicity (Three-class) | Non-required | 0.7797 |